A new study challenges the accepted notion that neurologic damage occurs only during relapses in neuromyelitis optica spectrum disorder (NMSOD). Using optical coherence tomography angiography (OCT-A), ...

Alexion Pharmaceuticals, AstraZeneca’s rare disease unit, shined a light on neuromyelitis optica spectrum disorder (NMOSD), a severe neurological disease, in a short film that debuted Thursday. While ...

"[There is] an opportunity within the healthcare space to create tools within the electronic medical record system that more effectively link symptoms and their duration, diagnostic study results, and ...

A recent meta-analysis revealed significant differences in characteristic between patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS), highlighting the need for ...

The data show Enspryng has a favorable benefit-risk profile and is effective in reducing relapses over four years of treatment in people with anti-aquaporin-4 antibody (AQP4-IgG) seropositive NMOSD, a ...

Please provide your email address to receive an email when new articles are posted on . Asymptomatic brain lesions were rarely observed on conventional MRI in patients with clinically stable, antibody ...

NMOSD is a unifying term for neuromyelitis optica (NMO) and related syndromes. NMOSD is a rare, severe, relapsing, neuroinflammatory autoimmune disease that attacks the optic nerve, spinal cord, brain ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new Ocrevus ® (ocrelizumab) data and continued research into ...

Cealie Lawrence went to work as a server at a Bob Evans in Westerville on what started like any other Tuesday morning in March 2005 when she suddenly went blind in both eyes. “I panicked,” said the ...